Our results found that silencing FOXD2-AS1 reduced the protein, but not the mRNA, expression levels of TERT in thyroid cancer cells, suggesting that FOXD2-AS1 regulates TERT expression at post-transcriptional level. Here, FOXD2 is linked to thyroid gland carcinoma.